Haploidentical HCT for Severe Aplastic Anemia

NCT04558736 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia
Bone Marrow Failure Syndrome

Interventions

DRUG: Anti-Thymocyte Globulin (Rabbit)
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Mesna
DRUG: G-CSF
RADIATION: Total Lymphoid Irradiation (TLI)
DEVICE: CliniMACS
BIOLOGICAL: HPC, A Infusion
BIOLOGICAL: CD45RA-depleted DLI

Sponsor

St. Jude Children's Research Hospital